Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.KR |
First Approval Date09 May 1995 |
100 Clinical Results associated with Osstem Cardio Co., Ltd.
0 Patents (Medical) associated with Osstem Cardio Co., Ltd.
100 Deals associated with Osstem Cardio Co., Ltd.
100 Translational Medicine associated with Osstem Cardio Co., Ltd.